ExcaliVir, Inc.

Biotechnology company · Doylestown, Pennsylvania, United States

ExcaliVir, Inc. is a biotechnology company headquartered in Doylestown, Pennsylvania, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $733,883 sold in a notice filed in 2016.

Profile compiled from public records. Is this your company? Request a correction or update

ExcaliVir at a glance

Typebiotechnology company

HeadquartersDoylestown, Pennsylvania, United States

Earliest incorporation on record2014

SEC CIK1685433

What does ExcaliVir do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $733,883 sold (2016).

Frequently asked questions about ExcaliVir

Where is ExcaliVir headquartered?

ExcaliVir, Inc. is headquartered in Doylestown, Pennsylvania, United States.

What does ExcaliVir do?

ExcaliVir, Inc. is a biotechnology company.

When was ExcaliVir founded?

The earliest incorporation on record for ExcaliVir, Inc. is in 2014, according to public company registers.

Similar companies

ImCare Biotech, Inc.Doylestown, Pennsylvania, United States
Thrombolex, Inc.Doylestown, Pennsylvania, United States
Prolifagen, Inc.Doylestown, Pennsylvania, United States
IVIEW Therapeutics IncDoylestown, Pennsylvania, United States
ImmunoGenesis, Inc.Doylestown, Pennsylvania, United States
Atrin Pharmaceuticals LLCDoylestown, Pennsylvania, United States
Fox Chase Chemical Diversity Center Inc.Doylestown, Pennsylvania, United States
Conifer Point Pharmaceuticals LLCDoylestown, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences